Loading
NTI Stock: price and insider trades · Australia
No insider purchase over the last 90 days. The latest was filed 28 Apr 2026.
NTI: what insiders have been doing
Insider filings for NTI are scarce in the ASX feed, the latest one published on 28 April 2026. This page will fill in as new trades are disclosed. Source: insider filings from ASX. Past trades are no guide to future returns.
Insider Decl.
1
Thresholds
n/a
Buy Volume
n/a
1 ops. · all time
Sell Volume
n/a
n/a
Who traded when
BuySaleUnknown1 buy
Fundamental score
Ranked 20,076 of 24,148 companies
28.3
score / 100
Value5
Quality52
FCF yld-43%
Earn yld-50%
EV/EBITDA·
ROE-66%
Gross mgn100%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended June 2025 · cache
A$0.01
Analyst consensus
Income statement
RevenueA$238
Gross profitA$238100% margin
EBITDA-A$13.2M-5537732% margin
Net income-A$10.6M-54.4% margin
Valuation
P/Book2.6x
Beta0.03
Balance sheet & cash
Market capA$21M
Free Cash Flow-A$9M
Profitability & ownership
ROE-66.3%
ROA-37.6%
% insiders23.4%
% institutions8.4%
Last declaration on 28 April 2026
About NTI
NTI is a company operating in the healthcare and pharmaceutical sector, listed on the XASX. It focuses on developing innovative solutions to enhance healthcare.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
